🇫🇷
France · FR · FR:60690011
KESIMPTA 20 mg, solution injectable en stylo prérempli
ReimbursedATC L04AG12
Last synced from Base de données publique des médicaments — BDPM (France) on
Identification
ManufacturerNOVARTIS EUROPHARM (IRLANDE)
CountryFR (France)
ATC codeL04AG12
Dispensing—
ReimbursedYes
SourceBase de données publique des médicaments — BDPM (France)
Last synced6/3/2026
Packs · 1
- cip1334009302269711 stylo prérempli en verre de 0,4 mlEUR 1.16
Annotations
No annotations yet.
Raw payload (JSON)
{
"cis": "60690011",
"date_amm": "2021-03-26",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/21/1532",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "solution injectable",
"voies_administration": "sous-cutanée",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}Related drugs
Other records sharing ATC code L04AG12.
- GBArzerra 1000mg/50ml concentrate for solution for infusion vialsNovartis Pharmaceuticals UK Ltd
- GBArzerra 100mg/5ml concentrate for solution for infusion vialsNovartis Pharmaceuticals UK Ltd
- PLKesimptaNovartis Ireland Ltd
- 🇨🇭KesimptaNovartis Pharma Schweiz AG
- FIKesimptaNovartis Europharm Limited
- DKKesimptaNovartis Europharm Limited
- DKKesimptaNovartis Europharm Limited
- ISKesimptaNovartis Europharm Limited*
Access this data programmatically
Query KESIMPTA 20 mg, solution injectable en stylo prérempli and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.